MedTrace Logo

Study of Arrhythmia and ECG Abnormalities in Patients With COVID-19

NCT04937621 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 196

Last updated 2021-06-24

No results posted yet for this study

Summary

Cardiac involvement has been described in Severe Acute Respiratory Syndrome - Coronavirus-2 (SARS-CoV-2) infection. Although there are no approved drugs to prevent or treat SARS-CoV-2 infection at present time, several medications used have the potential to increase QT interval and eventually provoke torsades de pointe. The investigators therefore create a study that include all patients with SARS-CoV-2 infection having an electrocardiogram (ECG). The investigators evaluate the percentage of patients with ECG abnormalities, describe the abnormalities and evaluate the occurrence of syncope, ventricular arrhythmia and corrected QT (cQT) interval modification in patients receiving treatment.

Conditions

Interventions

DIAGNOSTIC_TEST

ECG data analysis

Baseline ECG as well as follow-up ECG are analysed

DRUG

Treatment data collect

Baseline treatment data as well as follow-up treatment data are collected

BIOLOGICAL

Biological check-up data collect

Baseline Biological check-up data as well as follow-up data are collected

OTHER

Collection of clinical events of interest

Clinical events of interest at the baseline as well as follow-up clinical events are collected

Sponsors & Collaborators

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • frédéric Sacher, MD-PhD · University Hospital, Bordeaux

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-02
Primary Completion
2020-12-02
Completion
2020-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04937621 on ClinicalTrials.gov